Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1768, ahead of CRISPR Therapeutics (1116) and Kymera Therapeutics (264). Figures as of 18 Nov 2026, 20:48 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1768
Median
14.3
Combined market value
NOK 8.12T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
NOK
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1768NOK 69.2BNOK 775.10 1.28% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1116NOK 38BNOK 391.48 0.57% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care264NOK 100.4BNOK 1,176.36 0.15% down 87% up United States
4ImmunityBioIBRX · Health Care62.9NOK 69.1BNOK 64.97 7.06% up 193% up United States
5ModernaMRNA · Health Care41.2NOK 776.1BNOK 1,918.02 4.33% down 755% up United States
6Krystal BiotechKRYS · Health Care24.0NOK 90.7BNOK 3,059.43 5.70% up 46% up United States
7Twist BioscienceTWST · Health Care21.0NOK 76.5BNOK 1,122.70 3.40% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.6NOK 44.6BNOK 275.33 0.32% down 88% up United States
9RepligenRGEN · Health Care14.9NOK 106.8BNOK 1,671.28 6.30% up 5% up United States
10argenxARGX · Health Care14.3NOK 574.1BNOK 9,129.57 0.61% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4NOK 110.8BNOK 705.63 0.21% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.8NOK 105.8BNOK 927.60 0.30% down 37% up United States
13ExelixisEXEL · Health Care7.2NOK 161.9BNOK 663.61 0.07% down 63% up United States
14Gilead SciencesGILD · Health Care7.1NOK 2.04TNOK 1,640.84 0.59% down 33% up United States
15AmgenAMGN · Health Care6.5NOK 2.33TNOK 4,305.40 3.02% down 34% up United States
16BioNTechBNTX · Health Care6.5NOK 200.7BNOK 809.47 1.61% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.7NOK 159.4BNOK 1,574.53 2.12% down 20% up United States
18QiagenQGEN · Health Care4.9NOK 99.3BNOK 480.81 0.31% down 12% up Netherlands
19BiogenBIIB · Health Care3.8NOK 359.9BNOK 2,434.41 0.13% up 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6948 NOK). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1768), CRISPR Therapeutics (1116) and Kymera Therapeutics (264) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 20:48 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of NOK 8.12T as of 18 Nov 2026, 20:48 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.